Stage IE/IIE Extranodal NK/T-cell Lymphoma Arising From the Nasal Cavity: Investigation of Computed Tomography Findings and Its Prognostic Values

被引:0
|
作者
Kim, J.
Lee, S. [2 ]
Suh, C. [3 ]
Huh, J. [4 ]
Lee, B. [5 ]
Choi, E. [2 ]
Shin, H. [1 ]
Ahn, S. [2 ]
机构
[1] Bundang CHA Hosp, Dept Radiat Oncol, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Otolaryngol, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S619 / S620
页数:2
相关论文
共 50 条
  • [21] A randomized phase II study of CEOP with or without semustine as induction chemotherapy in patients with stage IE/IIE extranodal NK/T-cell lymphoma, nasal type in the upper aerodigestive tract
    Ma, Xuejun
    Guo, Ye
    Pang, Ziqiang
    Wang, Biyun
    Lu, Hongfen
    Gu, Ya-Jia
    Guo, Xiaomao
    RADIOTHERAPY AND ONCOLOGY, 2009, 93 (03) : 492 - 497
  • [22] Extranodal natural killer/T-cell lymphoma, nasal type: Clinical and computed tomography findings in the head and neck region
    Hung, Liang-Yueh
    Chang, Po-Hung
    Lee, Ta-Jen
    Hsu, Yin-Ping
    Chen, Yi-Wei
    Fu, Chia-Hsiang
    Huang, Chi-Che
    LARYNGOSCOPE, 2012, 122 (12): : 2632 - 2639
  • [23] A Multicenter Retrospective Comparison of Sequential versus Sandwich Chemoradiotherapy for Stage IE-IIE Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
    Li, Jin
    Li, Yajun
    Zhong, Meizuo
    Liu, Wei
    Liu, Xianling
    Li, Jiwei
    Li, Kunlun
    Yi, Pingyong
    JOURNAL OF CANCER, 2018, 9 (09): : 1598 - 1606
  • [24] Extranodal Natural Killer/T-Cell Lymphoma Nasal Type: Detection by Computed Tomography Features
    Hsu, Yin-Ping
    Chang, Po-Hung
    Lee, Ta-Jen
    Hung, Liang-Yueh
    Huang, Chi-Che
    LARYNGOSCOPE, 2014, 124 (12): : 2670 - 2675
  • [25] Pegaspargase with Concurrent Radiotherapy in a Once-Every-Three-Weeks Schedule in Patients with Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: A Phase II Study
    Wang, Hua
    Luo, Wei
    Lu, Yue
    BLOOD, 2018, 132
  • [26] Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study
    Kim, Seok Jin
    Kim, Kihyun
    Kim, Byung Soo
    Kim, Chul Yong
    Suh, Cheolwon
    Huh, Jooryung
    Lee, Sang-Wook
    Kim, Jin Seok
    Cho, Jaeho
    Lee, Gyeong-Won
    Kang, Ki Mun
    Eom, Hyeon Seok
    Pyo, Hong Ryull
    Ahn, Yong Chan
    Ko, Young Hyeh
    Kim, Won Seog
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) : 6027 - 6032
  • [27] Serum Ferritin Level As a Prognostic Factor for Patients with Extranodal NK/T-Cell Lymphoma, Nasal Type
    Yamazaki, Etsuko
    Tomita, Naoto
    Koyama, Satoshi
    Kishimoto, Kumiko
    Ogusa, Eriko
    Ishii, Yoshimi
    Takahashi, Hiroyuki
    Miyashita, Kazuho
    Matsuura, Shiro
    Tachibana, Takayoshi
    Takasaki, Hirotaka
    Takemura, Sachiya
    Fujimaki, Katsumichi
    Sakai, Rika
    Fujisawa, Shin
    Ishigatsubo, Yoshiaki
    BLOOD, 2012, 120 (21)
  • [28] Extranodal NK/T-cell Lymphoma, Nasal Type, Possibly Arising from Chronic Epstein-Barr Virus Infection
    Seishima, Mariko
    Yuge, Masaaki
    Kosugi, Hiroshi
    Nagasaka, Tetsuro
    ACTA DERMATO-VENEREOLOGICA, 2010, 90 (01) : 102 - 103
  • [29] EXTRANODAL NK/T-CELL LYMPHOMA, NASAL TYPE OF ADVANCED STAGE: NKEA (NEXT-GENERATION THERAPY FOR NK/T-CELL LYMPHOMA IN EAST ASIA) PROJECT
    Suzuki, R.
    Yamaguchi, M.
    Oguchi, M.
    Asano, N.
    Tomita, N.
    Amaki, J.
    Ando, T.
    Niitsu, N.
    Sekiguchi, N.
    Takizawa, J.
    Miyazaki, K.
    Katayama, N.
    HAEMATOLOGICA, 2016, 101 : 388 - 389
  • [30] First-line gemcitabine, oxaliplatin, and l-asparaginase chemotherapy followed by involved field radiation in stage IE/IIE extranodal NK/T-cell lymphoma
    Xia, Z. J.
    Wang, Z. H.
    Li, S.
    Chen, X. Q.
    Wang, F. H.
    Xu, F.
    Zhou, N. N.
    Xia, Y.
    Li, Y. J.
    Wang, K. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)